Currently, there are 865.50M common shares owned by the public and among those 855.95M shares have been available to trade.
The company’s stock has a 5-day price change of -11.45% and -12.59% over the past three months. MRVL shares are trading 3.02% year to date (YTD), with the 12-month market performance up to 51.43% higher. It has a 12-month low price of $36.90 and touched a high of $85.76 over the same period. MRVL has an average intraday trading volume of 14.32 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -11.26%, -11.64%, and 1.62% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Marvell Technology Inc (NASDAQ: MRVL) shares accounts for 84.58% of the company’s 865.50M shares outstanding.
It has a market capitalization of $53.80B and a beta (3y monthly) value of 1.47. The earnings-per-share (ttm) stands at -$1.08. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.52% over the week and 4.10% over the month.
Analysts forecast that Marvell Technology Inc (MRVL) will achieve an EPS of $MVRL for the current quarter, $27.88 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Maravai LifeSciences Holdings, while analysts give the company a high EPS estimate of $PRVL. Comparatively, EPS for the current quarter was $CorVel Corp. a year ago. Earnings per share for the fiscal year are expected to decrease by -5.54%, and 73.39% over the next financial year. EPS should grow at an annualized rate of 18.20% over the next five years, compared to -29.04% over the past 5-year period.
Looking at the support for the MRVL, a number of firms have released research notes about the stock. Evercore ISI stated their Outperform rating for the stock in a research note on April 16, 2024, with the firm’s price target at $88. TD Cowen was of a view on March 08, 2024 that the stock is Outperform, while Cantor Fitzgerald gave the stock Overweight rating on January 23, 2024, issuing a price target of $80. ROTH MKM on their part issued Buy rating on November 14, 2023.
